Current management of aromatase inhibitor-induced arthralgia

Journal of B.U.ON.

Volumn 21, Issue 1, 2016, Pages 17-20

  Sahin, Suleyman ^a   Karatas, Fatih ^a   Sever, Ali R ^a   Altundag, Kadri ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Aromatase inhibitors; Arthralgia; Breast cancer; Treatment

Indexed keywords

AROMATASE; AROMATASE INHIBITOR; CALCITRIOL; CYCLOOXYGENASE 2 INHIBITOR; ESTROGEN; IBUPROFEN; INTERLEUKIN 6; LETROZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYGENASE; PARACETAMOL; PLACEBO; PREDNISOLONE; TAMOXIFEN; TRICYCLIC ANTIDEPRESSANT AGENT; VITAMIN D; VITAMIN D RECEPTOR;

ACUPUNCTURE; ALGORITHM; AROMATASE INHIBITOR INDUCED ARTHRALGIA; ARTHRALGIA; BREAST CANCER; CARPAL TUNNEL SYNDROME; CHONDROPROTECTION; CLINICAL PRACTICE; COLLAGEN DEGRADATION; DRUG INDUCED DISEASE; ELECTROMYOGRAPHY; ESTROGEN DEFICIENCY; HIGH RISK PATIENT; HORMONE SUBSTITUTION; HUMAN; INFLAMMATION; JOINT EFFUSION; MULTICENTER STUDY (TOPIC); MUSCLE STRENGTH; OSTEOARTHRITIS; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYNOVIOCYTE; CHEMICALLY INDUCED;

AROMATASE INHIBITORS; ARTHRALGIA; HUMANS;

EID: 84969134533     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Bae K, Yoo HS, Lamoury G, Boyle F, Rosenthal DS, Oh B. Acupuncture for Aromatase Inhibitor-Induced Arthralgia: A Systematic Review. Integr Cancer Ther 2015;14:496-502.
2. Howell A, Cuzick J, Baum M et al. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 2005;365:60-62.
3. Burstein HJ, Temin S, Anderson H et al. Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American Society of Clinical Oncology Clinical Practice Guideline focused update. J Clin Oncol 2014;32:2255-2269.
4. Burstein HJ, Prestrud AA, Seidenfeld J et al. American Society of Clinical Oncology Clinical Practice Guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J Clin Oncol 2010;28:3784-3796.
5. Irwin ML, Cartmel B, Gross CP et al. Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors. J Clin Oncol 2015;33:1104-1111.
6. Prieto-Alhambra D, Javaid MK, Servitja S et al. Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: a prospective cohort study. Breast Cancer Res Treat 2011;125:869-878.
7. Burstein HJ Aromatase inhibitor-associated arthralgia syndrome. Breast 2007;16:223-234.
8. Felson DT, Cummings SR. Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation. Arthritis Rheumatism 2005;52:2594-2598.
9. Schaible HG Spinal mechanisms contributing to joint pain. Novartis Foundation symposium. 2004;260:4-22; discussion -7, 100-4, 277-9.
10. Vegeto E, Bonincontro C, Pollio G et al. Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J Neurosci 2001;21:1809-1818.
11. Smith YR, Stohler CS, Nichols TE, Bueller JA, Koeppe RA, Zubieta JK. Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women. J Neurosci 2006:26:5777-5785.
12. Gaillard S, Stearns V. Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management. Breast Cancer Res 2011;13:205.
13. Morales L, Pans S, Verschueren K et al. Prospective study to assess short-term intra-articular and tenosynovial changes in the aromatase inhibitor-associated arthralgia syndrome. J Clin Oncol 2008;26:3147-3152.
14. Sestak I, Cuzick J, Sapunar F et al. Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis. Lancet Oncol 2008;9:866-872.
15. Niravath P. Aromatase inhibitor-induced arthralgia: a review. Ann Oncol 2013;24:1443-1449.
16. Younus J, Kligman L. Management of aromatase inhibitor-induced arthralgia. Curr Oncol 2010;17:87-90.
17. Mao JJ, Bruner DW, Strieker C et al. Feasibility trial of electroacupuncture for aromatase inhibitor-related arthralgia in breast cancer survivors. Integr Cancer Ther 2009;8:123-129.
18. Galantino ML, Desai K, Greene L, Demichele A, Strieker CT, Mao JJ. Impact of yoga on functional outcomes in breast cancer survivors with aromatase inhibitor-associated arthralgias. Integr Cancer Ther 2012;11:313-320.
19. Khan QJ, Reddy PS, Kimler BF et al. Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer. Breast Cancer Res Treat 2010;119:111-118.
20. Kubo M, Onishi H, Kuroki S et al. Short-term and lowdose prednisolone administration reduces aromatase inhibitor-induced arthralgia in patients with breast cancer. Anticancer Res 2012;32:2331-2336.
21. Briot K, Tubiana-Hulin M, Bastit L, Kloos I, Roux C. Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study. Breast Cancer Res Treat 2010;120:127-134.
22. Castel LD, Hartmann KE, Mayer IA et al. Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohort. Cancer 2013;119:2375-2382.